Literature DB >> 12745102

Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy.

Barry J Maron1, Susan A Casey, David G Hurrell, Dorothee M Aeppli.   

Abstract

Left ventricular (LV) wall thickening is the most consistent clinical marker of hypertrophic cardiomyopathy (HC), and characteristically increases substantially during adolescence. In this study, we used 2-dimensional echocardiography to develop a cross-sectional profile of LV wall thicknesses in adult patients with HC. We studied a regional community-based cohort of 239 consecutively enrolled patients (aged 18 to 91 years). On average, maximum LV wall thickness decreased relative to increasing age (p = 0.007) within 4 age groups: 22.8 +/- 5.1 mm (18 to 39 years) to 22.1 +/- 5.1 mm (40 to 59 years) to 21.1 +/- 3.7 mm (60 to 74 years) to 20.8 +/- 3.6 mm (>or=75 years). The LV thickness index (summation of wall thicknesses in all 4 segments) also decreased with age (p = 0.017): 63.0 +/- 12.2 mm to 59.8 +/- 11.9 mm to 58.3 +/- 10.4 mm to 57.9 +/- 9.8 mm. Decreasing magnitude of LV hypertrophy was independently associated with increasing age, but not with other relevant disease variables, such as symptoms and outflow obstruction. However, when separated by gender, this inverse relation between age and LV wall thickness was statistically significant only for women (p = 0.007). In conclusion, in an unselected HC cohort, cross-sectional analysis showed a modest but statistically significant inverse relation between age and LV hypertrophy that was largely gender-specific for women. This association constitutes another facet of the natural history of this complex and heterogenous disease and may reflect disproportionate occurrence of premature death in young patients with HC with marked hypertrophy or possibly gradual LV remodeling.

Entities:  

Mesh:

Year:  2003        PMID: 12745102     DOI: 10.1016/s0002-9149(03)00266-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study.

Authors:  Stefano De Castro; Stefano Caselli; Martin Maron; Antonio Pelliccia; Elena Cavarretta; Prasad Maddukuri; Domenico Cartoni; Emanuele Di Angelantonio; Jeffrey T Kuvin; Ayan R Patel; Natesa G Pandian
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

2.  Hypertrophic Cardiomyopathy in Youth Athletes: Successful Screening With Point-of-Care Ultrasound by Medical Students.

Authors:  J Christian Fox; Shadi Lahham; Graciela Maldonado; Suzi Klaus; Bassil Aish; Lauren V Sylwanowicz; Justin Yanuck; Sean P Wilson; Mason Shieh; Craig L Anderson; Carter English; Ryan Mayer; Uthara R Mohan
Journal:  J Ultrasound Med       Date:  2017-03-04       Impact factor: 2.153

3.  Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.

Authors:  Eric C Wooten; Virginia B Hebl; Matthew J Wolf; Sarah R Greytak; Nicole M Orr; Isabelle Draper; Jenna E Calvino; Navin K Kapur; Martin S Maron; Iftikhar J Kullo; Steve R Ommen; J Martijn Bos; Michael J Ackerman; Gordon S Huggins
Journal:  Circ Cardiovasc Genet       Date:  2012-12-19

Review 4.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

5.  Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.

Authors:  J Martijn Bos; Jeanne L Theis; A Jamil Tajik; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2008-02-21       Impact factor: 4.749

6.  The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy.

Authors:  Iris C R M Kolder; Michelle Michels; Imke Christiaans; Folkert J Ten Cate; Danielle Majoor-Krakauer; Alexander H J Danser; Robert H Lekanne Deprez; Michael W T Tanck; Arthur A M Wilde; Connie R Bezzina; Dennis Dooijes
Journal:  Eur J Hum Genet       Date:  2012-05-09       Impact factor: 4.246

Review 7.  Androgen receptor (AR) in cardiovascular diseases.

Authors:  Chiung-Kuei Huang; Soo Ok Lee; Eugene Chang; Haiyan Pang; Chawnshang Chang
Journal:  J Endocrinol       Date:  2016-01-14       Impact factor: 4.286

8.  Cardiac manifestations of PRKAG2 mutation.

Authors:  Pooya Banankhah; Gregory A Fishbein; Anthony Dota; Reza Ardehali
Journal:  BMC Med Genet       Date:  2018-01-03       Impact factor: 2.103

9.  Hypertrophic Cardiomyopathy: Prevalence, Hypertrophy Patterns, and Their Clinical and ECG Findings in a Hospital at Qatar.

Authors:  Sherif M Helmy; Gomaa F Maauof; Ahmed A Shaaban; Ahmed M Elmaghraby; Smitha Anilkumar; Abdel Halim H Shawky; Rachel Hajar
Journal:  Heart Views       Date:  2011-10

10.  An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography.

Authors:  Ashraf M Anwar; Osama I I Soliman; Attila Nemes; Marcel L Geleijnse; Folkert J ten Cate
Journal:  Int J Cardiovasc Imaging       Date:  2007-05-31       Impact factor: 2.357

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.